Amy Z Fan1, Tara W Strine, Ruth Jiles, Ali H Mokdad. 1. Behavioral Surveillance Branch, Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. afan@cdc.gov
Abstract
OBJECTIVE: To highlight the close association of cardiovascular disease (CVD) with depression and anxiety in US non-institutionalized adults and examine the sociodemographic correlates of depression and anxiety among CVD survivors. METHOD: The data were obtained from 38 states which administered an Anxiety and Depression Module as part of the 2006 Behavioral Risk Factor Surveillance System. CVD was assessed with three questions on coronary heart disease and stroke. Adjusted prevalence ratios (APRs) were obtained after adjustment for demographic characteristics using SUDAAN 9.0. RESULTS: The prevalence of a CVD history was 15.3% among studied population (sample size n=129,499). Persons with a CVD history were more likely than those without to experience current depression (15.8% versus 7.1%, APR [95% CI]=1.69 [1.54-1.85]), to have a lifetime diagnosis of depressive disorders (22.3% versus 15.1%, APR [95% CI]=1.56 [1.45-1.67]) or anxiety disorders (16.6% versus 10.0%, APR [95% CI]=1.46 [1.37-1.54]). CVD survivors with low education attainment or minority background were less likely to receive a diagnosis of depression though their experience of depression was comparable with or higher than their counterparts. CONCLUSION: CVD is associated significantly with depression and anxiety. Disparities exist among CVD survivors on the diagnosis of depression and anxiety.
OBJECTIVE: To highlight the close association of cardiovascular disease (CVD) with depression and anxiety in US non-institutionalized adults and examine the sociodemographic correlates of depression and anxiety among CVD survivors. METHOD: The data were obtained from 38 states which administered an Anxiety and Depression Module as part of the 2006 Behavioral Risk Factor Surveillance System. CVD was assessed with three questions on coronary heart disease and stroke. Adjusted prevalence ratios (APRs) were obtained after adjustment for demographic characteristics using SUDAAN 9.0. RESULTS: The prevalence of a CVD history was 15.3% among studied population (sample size n=129,499). Persons with a CVD history were more likely than those without to experience current depression (15.8% versus 7.1%, APR [95% CI]=1.69 [1.54-1.85]), to have a lifetime diagnosis of depressive disorders (22.3% versus 15.1%, APR [95% CI]=1.56 [1.45-1.67]) or anxiety disorders (16.6% versus 10.0%, APR [95% CI]=1.46 [1.37-1.54]). CVD survivors with low education attainment or minority background were less likely to receive a diagnosis of depression though their experience of depression was comparable with or higher than their counterparts. CONCLUSION: CVD is associated significantly with depression and anxiety. Disparities exist among CVD survivors on the diagnosis of depression and anxiety.
Authors: Ying L Liu; Moyses Szklo; Karina W Davidson; Joan M Bathon; Jon T Giles Journal: Arthritis Care Res (Hoboken) Date: 2015-10 Impact factor: 4.794
Authors: Chizobam Ani; Mohsen Bazargan; David Hindman; Douglas Bell; Michael Rodriguez; Richard S Baker Journal: J Am Board Fam Med Date: 2009 Mar-Apr Impact factor: 2.657
Authors: Christi S Ulmer; Hayden B Bosworth; Anne Germain; Jennifer Lindquist; Maren Olsen; Mira Brancu; Jean C Beckham Journal: J Behav Med Date: 2015-03-27
Authors: Thomas Rutledge; Sarah E Linke; David S Krantz; B Delia Johnson; Vera Bittner; Jo-Ann Eastwood; Wafia Eteiba; Carl J Pepine; Viola Vaccarino; Jennifer Francis; Diane A Vido; C Noel Bairey Merz Journal: Psychosom Med Date: 2009-10-15 Impact factor: 4.312